. Author manuscript; available in PMC: 2020 Jul 1.

Published in final edited form as: Int Forum Allergy Rhinol. 2019 Jun 4;9(7):759–765. doi: 10.1002/alr.22332

Table 3:

Predictors of Symptom Severity (SNOT-22)

Patient Characteristic	Panel coefficient (p-value)	Coefficient Interaction with Time^*(p-value)
Age	0.07 (0.94)	0.02 (0.37)
Female Sex	8.69 (0.29)	0.06 (0.80)
FEV₁ % predicted	−0.11 (0.39)	0.01 (0.010)
BMI	−0.79 (0.29)	0.057 (0.080)
CFRD	18.22 (0.008)	0.32 (0.11)
Allergic rhinitis	10.15 (0.21)	−0.18 (0.39)
Nasal steroid	−9.02 (0.26)	−0.37 (0.067)
Azithromycin use	−1.01 (0.91)	0.12 (0.54)
P. aeruginosa in Sinus	−1.19 (0.65)	−0.39 (0.053)
S. aureus in Sinus	−1.08 (0.65)	0.47 (0.023)
CRS Exacerbation visit	4.86 (0.017)	−0.11 (0.70)

in months